ALBERT DARAKJY: Open Payments
NPI 1669953675 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 15 payments from 6 companies in 2025. Trend: 2023 $83 · 2024 $127 · 2025 $399
Food & beverage: $296Education: $103
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $168 |
| Teva Pharmaceuticals USA, Inc. | 1 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| PFIZER INC. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $17 |
Products named: CAPLYTA, REXULTI, PREVNAR 20, INGREZZA, UBRELVY.
Industry payments across ID — which companies pay providers there.
